Fibrosing Alveolitis

Fibrosing alveolitis, now usually called idiopathic pulmonary fibrosis, is a lung disease in which scar tissue builds up in the air sacs and makes breathing harder. It needs treatment from a physician, often a lung specialist. At Netra Integrative Health Clinic in South Plainfield, NJ, acupuncture, Ayurvedic medicine and herbal medicine are offered only as supportive care alongside that treatment, not as a treatment for the scarring itself.

Fibrosing Alveolitis
At a glance
  • What it is: A progressive lung disease in which scarring of the lung tissue makes the lungs stiff and reduces oxygen transfer. Fibrosing alveolitis is an older name for idiopathic pulmonary fibrosis (IPF).
  • Common symptoms: Gradual shortness of breath, a dry cough that does not go away, tiredness, and sometimes finger clubbing.
  • Conventional care: Specialist care with antifibrotic medicines, supplemental oxygen when needed, pulmonary rehabilitation, and lung transplant in selected severe cases.
  • How integrative care fits: Acupuncture, Ayurvedic therapies and individually prescribed herbs may be used as supportive care for symptoms such as breathlessness, stress and tiredness, with your lung specialist aware.
  • Evidence at a glance: Research on the disease itself is limited to small, mostly Chinese trials of herbal formulas and moxibustion; acupuncture has been studied for breathlessness in other lung diseases; no clinical trials of Ayurveda were found.

What is Fibrosing Alveolitis?

Fibrosing alveolitis is a lung disease in which scar tissue gradually replaces healthy tissue around the air sacs (alveoli), where oxygen passes into the blood. The term is an older name for idiopathic pulmonary fibrosis (IPF), meaning scarring of the lungs with no known cause. IPF tends to progress, and the long-term outlook is serious, with a median survival of about 2 to 5 years from diagnosis in one overview.[1, 2]

For a condition like this, we ask that you are under a physician's care for it and that your treating team knows you are receiving complementary care.

Common symptoms

The classic features are shortness of breath that comes on slowly and gets worse over time, and a dry cough with no phlegm.[1] Cough can be a heavy burden. Studies describe disrupted daily activities, tiredness and social embarrassment, and a lower quality of life when cough is severe.[3]

  • Tiredness and reduced ability to exercise
  • Chest tightness or discomfort
  • Widening and rounding of the fingertips (clubbing)
  • Anxiety and low mood, which are common. A review of 25 studies found rates that varied widely depending on how they were measured, from roughly 7 to 15 percent for formal diagnoses to about 38 to 42 percent on screening questionnaires.[4]

Causes and risk factors

In most people no cause is found, which is why the word idiopathic is used. Known contributors include smoking, inhaled dusts such as asbestos and silica, a family history of lung scarring, and older age; scarring of the same kind can also accompany autoimmune diseases such as rheumatoid arthritis, scleroderma and lupus.[1, 2] Stomach acid reaching the lungs is thought to play a role in some people.[1]

How it is diagnosed and treated conventionally

Diagnosis rests on your history, breathing tests and a high-resolution CT scan of the chest, which shows a typical pattern of scarring at the lung bases. A lung biopsy is used only when the picture is unclear, because it carries risks.[1] An international guideline considers a cryobiopsy an acceptable alternative to surgical biopsy in experienced centers.[5]

Care is directed by a lung specialist. Treatment includes antifibrotic medicines (pirfenidone and nintedanib) that aim to slow the decline in lung function, oxygen when blood levels fall, and lung transplant for selected people with severe disease.[1] Nintedanib commonly causes digestive side effects.[6] Corticosteroids and other immune-suppressing drugs are not standard treatment for IPF itself, although they may be used when scarring comes with an autoimmune disease. Pulmonary rehabilitation, a supervised program of exercise and education, probably improves walking distance and quality of life and may reduce breathlessness in interstitial lung disease, including IPF.[7]

Why Fibrosing Alveolitis calls for a whole-person approach

Scarring in the lungs is not the only thing a person with this disease has to manage. Breathlessness, cough, poor sleep, worry and loss of stamina all affect daily life, and they can feed each other.

None of the factors below treats the lung scarring. They are areas where supportive care may help you feel better while your specialist manages the disease.

Breathlessness and exercise capacity

Breathlessness limits activity, and inactivity weakens the body further. Pulmonary rehabilitation has moderate-certainty evidence for improving walking distance in interstitial lung disease, including IPF.[7]

Cough

Persistent cough disrupts sleep and social life and is tied to a lower quality of life in IPF.[3]

Anxiety and low mood

Anxiety and depression are common in people with IPF, although reported rates vary widely.[4] Raise any persistent low mood or worry with your doctor.

Reflux and digestive symptoms

Reflux is common alongside IPF, and side effects of antifibrotic medicine often affect the gut.[1, 6] A guideline made conditional recommendations against antacid medication and antireflux surgery as treatments for IPF itself, so decisions about reflux medicine belong with your physician.[5]

Acupuncture as supportive care in Fibrosing Alveolitis

What the research shows

No clinical trials of needle acupuncture for idiopathic pulmonary fibrosis itself were found in a PubMed search, so we cannot say that it helps the disease. The nearest evidence is for breathlessness in other chronic lung conditions.

A 2024 meta-analysis of 23 trials in chronic respiratory diseases such as COPD, lung cancer and asthma found that acupuncture reduced breathlessness and improved walking distance and quality of life, with results that held when compared with sham acupuncture. The authors called for larger, higher-quality trials.[8] In China, a trial of 116 people with IPF and acid reflux added umbilical moxibustion (warming the area around the navel with burning mugwort) to routine care. It reported better symptom scores and walking distance than routine care alone, with no difference in a quality of life questionnaire right after treatment.[9] A 2025 meta-analysis of 11 trials of external traditional Chinese treatments (a group that includes moxibustion) added to conventional care in IPF reported better lung function and walking distance, but the authors noted that the studies were few and of limited quality.[10]

How acupuncture may work

No studies explain how acupuncture might act on lung scarring, and we do not suggest that it does. Any benefit for breathlessness is a symptom-level effect, and the mechanisms are not settled.

What treatment involves

Treatment uses fine, sterile, single-use needles placed at points on the chest, back, arms and legs, usually left in for about 20 to 40 minutes. A course is several visits, with reassessment along the way. Sessions can be adapted for people who tire easily or need to sit upright.

Serious problems are rare. In prospective studies, about 9 in 100 patients had a minor reaction such as brief bleeding, soreness or redness at a needle site, and serious events occurred in about 1 in 10,000 patients.[11] Tell the practitioner first if you use supplemental oxygen, have a bleeding disorder, take blood thinners, are pregnant, or have a pacemaker (relevant to electroacupuncture). Needling over the chest is done with particular care in people with lung disease.

Ayurvedic medicine as supportive care in Fibrosing Alveolitis

The Ayurvedic view

Ayurveda has no exact counterpart to pulmonary fibrosis. Practitioners may describe chronic breathlessness and dry cough as a disturbance of the lung-related patterns of Vata and Kapha, and weak digestion (agni) is traditionally seen as contributing. These are traditional frameworks, not biomedical diagnoses.

Therapies that may be used

Supportive options in this tradition include regular, warm, easily digested meals, a steady daily routine, gentle breathing practices such as pranayama within your comfort, and calming practices for stress and sleep. Individually prescribed herbs may be used, with attention to your medicines.

Panchakarma, the traditional cleansing program, is not appropriate during pregnancy, acute illness or frailty. It is generally unsuitable for people with advanced lung disease, low oxygen levels or marked weakness, so it should not be used in that situation. An herbal preparation applied to the skin (transdermal medication therapy) may be considered for local comfort only.

What the research shows

We found no clinical trials of Ayurvedic treatment for pulmonary fibrosis, so there is no evidence that it helps this disease. Curcumin, the main pigment in turmeric, has been studied for lung diseases including pulmonary fibrosis, but a review found the evidence sparse and mostly from cell and animal experiments, with poor absorption in humans as a major problem.[12] Those laboratory findings do not show that turmeric helps people with IPF.

Ayurvedic products also carry a quality risk. In one study, about one fifth of Ayurvedic medicines bought online contained detectable lead, mercury or arsenic.[13]

Herbal medicine as supportive care in Fibrosing Alveolitis

Herbs and formulas that have been studied

Most research is from China and tests multi-herb formulas, often with astragalus (Astragalus, huangqi) and angelica root (dang gui, Angelica sinensis) among the ingredients. Named formulas tested in IPF include Jinbei oral liquid and Qizhukangxian granules.[14, 15]

What the research shows

The evidence is limited and of low quality. A meta-analysis of 25 trials with 1,471 people found that Chinese medicine was linked to fewer exacerbations, better lung function and walking distance and fewer adverse effects than control treatments, but no clear difference in death rates. The authors rated the studies as low quality.[16] A review of 17 trials of astragalus and angelica reported better lung function and exercise tolerance, though its abstract does not say how reliable the underlying trials were.[17]

Two placebo-controlled trials are more informative. In a 120-person pilot trial of Qizhukangxian granules over 48 weeks, the herbal group did better on several lung function and symptom measures, with no adverse reactions reported.[15] In a 68-person analysis of Jinbei oral liquid over 26 weeks, total lung capacity fell less than with placebo, but changes in other lung function measures and in a quality of life score were not statistically significant. The authors describe it as exploratory.[14] All of these studies were done in China and used formulas that are not the same as what we would prescribe individually, so the results may not apply.

Safety and herb-drug interactions

Herbs can interact with medicines. Reviews describe bleeding when warfarin is taken with danshen, ginkgo and garlic, and lowered ciclosporin levels with St. John's wort, which led to organ rejection in some cases.[18] People with IPF may take blood thinners, immune-suppressing drugs or antifibrotic medicines, so every herb needs review against your full medicine list. Dietary and herbal supplements are also a recognized cause of liver injury, which matters if your medicines affect the liver.[19]

Tell us if you are pregnant or breastfeeding, have liver or kidney disease, or have surgery planned. Products should come from tested sources, and herbs are prescribed individually, never as a substitute for your lung medicines.

Translating traditional medicine into modern biological language

This section is interpretation, not equivalence. Traditional Chinese medicine often describes chronic cough and breathlessness with lung and spleen qi deficiency or yin deficiency, and the herb formulas above are chosen by pattern. Researchers instead look for effects on inflammation, oxidative stress and scarring signals in laboratory studies, and the review that summarizes this work calls for proper clinical trials.[20]

Ayurveda's idea of impaired agni or aggravated Vata has no established biological match. No study has shown that a dosha, a qi pattern or a herbal action corresponds to a measurable change in lung scarring.

How this care fits with your medical care

Supportive care here is complementary. Keep seeing your lung specialist, keep taking prescribed medicines, and do not stop or change antifibrotics, oxygen, steroids or any other treatment without your physician. We do not diagnose or manage pulmonary fibrosis, and we do not prescribe or adjust drugs.

Please bring your diagnosis, recent CT and breathing test results, your oxygen prescription if you have one, and a complete list of medicines and supplements. If you are on a transplant list or planning a procedure, tell us so herbs can be reviewed beforehand.

When to seek urgent medical care

Pulmonary fibrosis can worsen suddenly, and some changes need same-day medical attention.

  • Breathlessness that is rapidly worse than usual or occurs at rest
  • Blue or gray lips or fingertips, or confusion
  • Fever with a new cough, or coughing up blood
  • Chest pain, especially sudden pain with breathlessness
  • Swelling of one leg, which can signal a blood clot
  • Oxygen readings well below your usual target

If you have any of these, call 911 or go to the nearest emergency department.

Frequently asked questions

What is fibrosing alveolitis?

Fibrosing alveolitis is an older name for idiopathic pulmonary fibrosis, a lung disease in which scar tissue builds up around the air sacs. The lungs become stiff and move less oxygen into the blood. People usually notice slowly worsening breathlessness and a dry cough. It is diagnosed and treated by physicians, often lung specialists, and tends to progress over time.

Can acupuncture help people with fibrosing alveolitis?

Acupuncture has not been tested in good trials for pulmonary fibrosis itself, and it does not treat the scarring. A 2024 meta-analysis in chronic lung diseases such as COPD and lung cancer suggested it may ease breathlessness. The authors called for larger, higher-quality trials. We offer it only as supportive care alongside your specialist’s treatment.

Does Ayurvedic or herbal medicine work for fibrosing alveolitis?

No clinical trials of Ayurveda for pulmonary fibrosis were found. Chinese herbal formulas have been tested in small trials, mostly in China, with some better lung function and walking measures, but the studies were generally low quality. Herbs can interact with medicines, so any herb must be reviewed against your medication list.

Can I stop my antifibrotic medicine or oxygen if I have this care?

No. Acupuncture, Ayurveda and herbal medicine are complementary and cannot replace prescribed treatment. Do not stop or change antifibrotic medicines, steroids or oxygen without your physician. Sudden worsening of breathing needs urgent medical care, not an appointment with us.

How soon might I notice a change?

This differs from person to person and no result can be promised. Any benefit would be to symptoms such as breathlessness, stress or sleep, not to the scarring. Progress is reassessed after a short course of visits to see whether the care is helping you.

What should I bring to my first visit, and does insurance cover acupuncture?

Bring your diagnosis, recent CT and breathing test results, and a full list of medicines and supplements. Insurance may cover acupuncture: Netra Integrative Health Clinic accepts most major plans with out-of-network acupuncture benefits, such as Aetna, Blue Cross Blue Shield, Cigna and UnitedHealthcare, and offers a free benefits check. Call (908) 402-7301.

References

  1. Sankari A, Chapman K, Ullah S. Idiopathic Pulmonary Fibrosis. StatPearls [Internet]. 2024. PMID 28846333. StatPearls chapter on idiopathic pulmonary fibrosis covering its progressive course, symptoms, CT-based diagnosis, and treatment with antifibrotics, oxygen and lung transplant.
  2. Kanchustambham V, Sankari A. Interstitial Lung Disease. StatPearls [Internet]. 2026. PMID 31082128. StatPearls chapter on interstitial lung disease covering classification, causes and presentation, noting median survival of 2 to 5 years in idiopathic pulmonary fibrosis.
  3. Green R, Baldwin M, Pooley N, et al. The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis. Respir Res. 2024;25(1):325. PMID 39192278. Systematic review of 61 studies describing how persistent cough affects quality of life, daily activity, tiredness and social life in IPF and other interstitial lung diseases.
  4. Xu L, Zang D, Yan R, et al. Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. BMC Pulm Med. 2026;26(1). PMID 42271338. 2026 meta-analysis of 25 studies showing anxiety and depression are common in IPF, with prevalence varying widely by how it is measured.
  5. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47. PMID 35486072. ATS/ERS/JRS/ALAT 2022 guideline update on IPF, with conditional recommendations on cryobiopsy and against antacid medication and antireflux surgery as IPF treatment.
  6. Cheema S, Saddique MN, Jha A, et al. Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Heart Lung. 2025;73:114-122. PMID 40382966. Meta-analysis of 4 trials of nintedanib in IPF (1,665 patients) finding signs of slowed progression but more gastrointestinal adverse events.
  7. Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2021;2(2):CD006322. PMID 34559419. Cochrane review of pulmonary rehabilitation in interstitial lung disease finding probable gains in walking distance, breathlessness and quality of life, with no rehabilitation-related adverse events reported.
  8. Yu Y, Xiao W, Du LY, et al. Acupuncture for dyspnea and breathing physiology in chronic respiratory diseases: A systematic review and meta-analysis of randomized controlled trials. Heliyon. 2024;10(10):e31176. PMID 38813170. 2024 meta-analysis of 23 trials of acupuncture for breathlessness in chronic respiratory diseases, finding less dyspnea and better walking distance, with a call for higher-quality studies.
  9. Li B, Zhang Y, Yang QM. [Umbilical moxibustion for patients with idiopathic pulmonary fibrosis complicated with gastroesophageal reflux of lung-spleen qi deficiency]. Zhongguo Zhen Jiu. 2019;39(3):241-5. PMID 30942008. Randomized trial of 116 people with IPF and acid reflux testing umbilical moxibustion added to routine care, reporting better symptom scores and walking distance.
  10. Li Y, Wu X, Xue Y, et al. Efficacy and safety of external treatment of traditional Chinese medicine combined with conventional treatment for idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Medicine (Baltimore). 2025;104(41):e45018. PMID 41088620. Meta-analysis of 11 trials of external traditional Chinese treatments added to conventional care in IPF, reporting better lung function and walking distance with limited study quality.
  11. Bäumler P, Zhang W, Stübinger T, et al. Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. BMJ Open. 2021;11(9):e045961. PMID 34489268. Systematic review of 21 prospective studies finding minor acupuncture reactions in about 9 percent of patients and serious events in about 1 per 10,000.
  12. Lelli D, Sahebkar A, Johnston TP, et al. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Res. 2017;115:133-148. PMID 27888157. Review of curcumin in lung diseases including pulmonary fibrosis, finding evidence sparse and mostly from laboratory and animal work, with poor absorption in humans.
  13. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-23. PMID 18728265. JAMA study finding detectable lead, mercury or arsenic in about one fifth of Ayurvedic medicines purchased over the Internet.
  14. Zhang A, Han K, Chen F, et al. Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial. Sci Rep. 2025;15(1):3007. PMID 39849152. Exploratory placebo-controlled trial of Jinbei oral liquid in 68 analyzed people with IPF, finding less fall in total lung capacity but no significant change in most other measures.
  15. Guo S, Song Y, Feng J, et al. Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial. J Tradit Chin Med. 2020;40(4):674-682. PMID 32744035. Placebo-controlled pilot trial of Qizhukangxian granules in 120 people with IPF over 48 weeks, reporting better lung function and symptom measures and no adverse reactions.
  16. Wu Q, Zhou Y, Feng FC, et al. Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Chin J Integr Med. 2019;25(10):778-784. PMID 29335860. Meta-analysis of 25 trials (1,471 patients) of Chinese medicine in IPF reporting fewer exacerbations and better lung function, limited by low study quality.
  17. Zhang Y, Gu L, Xia Q, et al. Radix Astragali and Radix Angelicae Sinensis in the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-analysis. Front Pharmacol. 2020;11:415. PMID 32425767. Systematic review of 17 trials of astragalus and angelica root in IPF reporting better lung function and exercise tolerance.
  18. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239-82. PMID 15916450. Literature review of herb-drug interactions describing bleeding with warfarin and danshen, ginkgo or garlic, and reduced ciclosporin levels with St. John's wort.
  19. Navarro VJ, Khan I, Björnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363-373. PMID 27677775. Hepatology review of liver injury from herbal and dietary supplements, which account for about 20 percent of drug-induced liver injury cases in the United States.
  20. Li LC, Kan LD. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects. J Ethnopharmacol. 2017;198:45-63. PMID 28038955. Review of laboratory and clinical research on traditional Chinese medicine in pulmonary fibrosis, suggesting effects on inflammation, oxidative stress and fibrosis signaling pathways.

This page is for general education and is not medical advice. Acupuncture, Ayurvedic medicine and herbal medicine are complementary therapies; they do not replace diagnosis or treatment by your physician. Do not stop or change prescribed treatment without talking to your prescriber. In an emergency call 911.

South Plainfield, New Jersey

Fibrosing Alveolitis care near you

Netra Integrative Health Clinic is at 5001 Hadley Rd, Ste 210, South Plainfield, NJ 07080, a short drive from Edison, Piscataway, Plainfield, Metuchen, Dunellen and Middlesex. We are open Monday to Friday, 10:00 AM to 8:00 PM, and see patients in person.

Care is provided by Dr. Saikumar Gandapodi, DAOM, Dipl. OM, L.Ac., a board certified and New Jersey licensed acupuncturist. Most major insurance plans with out-of-network acupuncture benefits are accepted, and we can check your benefits before your first visit.

Autoimmune & Inflammation

Related conditions

All in
Autoimmune & Inflammation
→
Board Certified and State Licensed Practitioner
NCCAOMDiplomate of Oriental MedicineNational Ayurvedic Medical Association